Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Circulating-tumor DNA sequencing of healthy samples

ABSTRACT: In this study we have sequenced the TP53 gene (exons) from circulating-tumor DNA of 125 controls samples. Each ctDNA samples was sequenced independently twice.

PROVIDER: EGAS00001003989 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

422aa293-1afb-4095-88ff-47754cd940fc - samples

Project description:BAM files corresponding to the sequencing of 125 circulating cell-free DNA from 125 healthy patients. Each sample was sequenced twice.

| EGAD00001005463 | EGA

Single Cell RNA-sequencing of Pancreatic Circulating Tumor Cells

Project description:Circulating Tumor Cells (CTCs) are shed from primary tumors into the bloodstream, mediating the hematogenous spread of cancer to distant organs. Using a pancreatic cancer mouse model, we applied a microfluidic device to isolate CTCs independently of tumor epitopes, subjecting these to single cell RNA-sequencing. This study was conducted to determine the heterogeneity of pancreatic CTCs and to compare these CTCs to matched primary tumors, cell line controls (NB508 cancer cell line and MEF non-cancer cell line), primary tumor single cells, and normal leukocytes/WBCs. We profiled RNA from 75 single cells circulating in mouse blood enriched for circulating tumor cells from 5 mice, 12 single cells from a mouse embryonic fibroblast cell line, 16 single cells from the nb508 mouse pancreatic cancer cell line, 12 single mouse white blood cells, 18 single GFP lineage-traced circulating tumor cells from two mice, 20 single GFP lineage-traced cancer cells from the primary pancreatic tumor of a mouse, and 34 dilutions to 10 or 100 picograms of total RNA from mouse primary pancreatic tumors from 4 mice.

2014-09-22 | E-GEOD-51372 | biostudies-arrayexpress

Presence of Circulating Tumor DNA in Colorectal Cancer

Project description:Cancer is a DNA disease characterized by the presence of genetics alterations in cancer cells. The recent studies underline that these recurring alterations must be considered as a good molecular marker. In fact, they could use for tumor DNA detection in different biological fluids. So, the main purpose is to define the presence of circulating tumor DNA in the patients plasma with colorectal cancer, by the presence of mutation (KRAS, NRAS, BRAF, APC, TP53 and MIRCOSATELLIE instability). These molecular analysis will be done both in tumor and plasma samples, This trial allows to characterize the prognostic value of circulating tumoral DNA presence in colorectal cancer.

| 2094858 | ecrin-mdr-crc

Amplicon-Screening of genomic DNA regions of mutants in the Exon5 R175 position of TP53 in HCT116 cells generated via CRISPR editing

Project description:To compare the impact of CRISPR-egineered R175 TP53 mutant variants in HCT116 and H460 cells, mutations at the amino acid position 175 were generated systematically by CRISP/Cas9 editing. Here, genomic amplicon regions covering the TP53 Exons 5 were sequenced via targeted sequencing.

2024-10-16 | E-MTAB-14322 | biostudies-arrayexpress

Single Cell RNA-sequencing of Pancreatic Circulating Tumor Cells

2014-09-22 | GSE51372 | GEO

Efficient Propagation of Circulating Tumor Cells: A First Step for Probing Tumor Metastasis.

Project description:Circulating Tumor Cells (CTCs) from metastatic breast cancer patients were harvested and grown in vitro for 30+ days in a novel short-term culture method. Additionally, RNA from the buffy coat of 5 healthy donors were sequenced and subjected to culture conditions; 0/5 cultures successfully grew. This new culture method is highly efficient and allows for the molecular characterization of CTCs and identification of potential targets for therapy against tumor metastasis. Using this method, we established 12/12 cultures of CTCs.

2020-04-21 | GSE148991 | GEO

Circulating RNA profiles of healthy and preeclamptic pregnancies

Project description:Circulating RNA profiles of healthy and preeclamptic pregnancies

| PRJNA626381 | ENA

Circulating RNA profiles of healthy and preeclamptic pregnancies

Project description:Circulating RNA profiles of healthy and preeclamptic pregnancies

| PRJNA626383 | ENA

Circulating Tumor DNA in Intermediate Risk Rhabdomyosarcoma

Project description:Circulating Tumor DNA in Intermediate Risk Rhabdomyosarcoma

| PRJNA823799 | ENA

Circulating Tumor DNA in Intermediate Risk Rhabdomyosarcoma

Project description:Circulating Tumor DNA in Intermediate Risk Rhabdomyosarcoma